Another Langer-backed biotech breaks out of stealth mode, aims for the clinic with hearing loss therapy
Over the last 18 months the team at Frequency Therapeutics’ Kendall Square office has been making quiet progress with its preclinical work on a new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
